Today news
Related News
Pfizer Vaccine Appears Safe For Kids Ages 5-11, Study Finds; Data Will Be Submitted To Regulators ASAP
Reading now: 136
deadline.comThe initial findings of an anticipated study into the effectiveness of the Pfizer-BioNTech Covid vaccine on children ages of 5-11 were released today, and the first results seem promising.In the second of three phases, the pharmaceutical giants enlisted 2,268 participants ages 5-11 in the United States, Finland, Poland and Spain.
While those ages 12 and up have been given 30 µg (microgram) doses, patients in the new study received a 10 µg dose level in a two-dose regimen.The trial demonstrated strong immune response in the group of children one month after the second dose.
That compares well – or was “non-inferior,” the companies said — to the results seen from participants ages 16-25, who were used as the control group for the analysis and
Read more on deadline.com
The website celebsbar.com is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.
